Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery

Background: Benign prostatic hyperplasia (BPH) is a frequent condition in ageing men. Surgery is recommended for severe BPH symptoms and BPH-related complications. TURP is the reference standard for BPH surgery, but carries a risk of bleeding, which can lead to significant perioperative morbidity an...

Full description

Saved in:
Bibliographic Details
Main Authors: Taofiq Olayinka Mohammed, Prashant M. Mulawkar, Pankaj Nandkishore Maheshwari, Abhishek Gajendra Singh, Vineet Gauhar, Gyanendra Sharma
Format: Article
Language:English
Published: The Société Internationale d’Urologie (SIU) 2024-12-01
Series:Société Internationale d’Urologie Journal
Subjects:
Online Access:https://www.mdpi.com/2563-6499/5/6/60
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846102728904802304
author Taofiq Olayinka Mohammed
Prashant M. Mulawkar
Pankaj Nandkishore Maheshwari
Abhishek Gajendra Singh
Vineet Gauhar
Gyanendra Sharma
author_facet Taofiq Olayinka Mohammed
Prashant M. Mulawkar
Pankaj Nandkishore Maheshwari
Abhishek Gajendra Singh
Vineet Gauhar
Gyanendra Sharma
author_sort Taofiq Olayinka Mohammed
collection DOAJ
description Background: Benign prostatic hyperplasia (BPH) is a frequent condition in ageing men. Surgery is recommended for severe BPH symptoms and BPH-related complications. TURP is the reference standard for BPH surgery, but carries a risk of bleeding, which can lead to significant perioperative morbidity and mortality. To reduce bleeding during TURP, antifibrinolytic agents like tranexamic acid (TXA) have been studied. We aim to review the current evidence regarding TXA use during transurethral BPH surgery. Objective: This review aims to assess the efficacy and safety of tranexamic acid in reducing bleeding during transurethral benign prostatic hyperplasia surgery. Methods: Major clinical research databases such as PubMed, Cochrane Central Register of Controlled Trials, EBSCO, Scopus, Google Scholar, and Web of Science were searched from 2012 to 2022 for randomised controlled trials (RCTs) comparing the use of TXA to placebo in transurethral BPH surgery using the PICOS format. We included RCTs without language restrictions that assessed intraoperative blood loss, transfusion rates, haemoglobin levels, length of hospital stay, postoperative thromboembolic events, and 30-day perioperative mortality as outcomes. The quality assessment of the included studies was performed using the Cochrane risk-of-bias tool, RoB 2, for randomised studies. Results: A total of six RCTs, which included 456 patients, were eventually included in the meta-analysis. The results showed that tranexamic acid is beneficial in reducing blood loss and minimising changes in haemoglobin levels during transurethral resection of the prostate. However, it does not lessen the need for blood transfusions or shorten the hospital stay. Conclusions: Tranexamic acid is useful in decreasing blood loss and reducing changes in haemoglobin in patients undergoing transurethral resection of the prostate. Its utility during BPH surgery in low-resource settings where the latest haemostatic enucleation techniques, such as holmium and GreenLight laser enucleation, may not be readily available needs further evaluation.
format Article
id doaj-art-97ff0b42ed484959a7ae94db9b10b83a
institution Kabale University
issn 2563-6499
language English
publishDate 2024-12-01
publisher The Société Internationale d’Urologie (SIU)
record_format Article
series Société Internationale d’Urologie Journal
spelling doaj-art-97ff0b42ed484959a7ae94db9b10b83a2024-12-27T14:53:41ZengThe Société Internationale d’Urologie (SIU)Société Internationale d’Urologie Journal2563-64992024-12-015681382210.3390/siuj5060060Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia SurgeryTaofiq Olayinka Mohammed0Prashant M. Mulawkar1Pankaj Nandkishore Maheshwari2Abhishek Gajendra Singh3Vineet Gauhar4Gyanendra Sharma5Division of Urology, Department of Surgery, University of Ilorin Teaching Hospital, Ilorin 241102, NigeriaDepartment of Urology, Government Medical College and Super Speciality Hospital, Akola 444005, IndiaDepartment of Urology, Fortis Hospital, Mulund, Mumbai 400078, IndiaDepartment of Urology, Muljibhai Patel Urological Hospital, Nadiad 387001, IndiaDivision of Urology, Ng Teng Fong General Hospital, Singapore 600046, SingaporeDepartment of Urology, Chitale Clinic Pvt Ltd., Solapur 413001, IndiaBackground: Benign prostatic hyperplasia (BPH) is a frequent condition in ageing men. Surgery is recommended for severe BPH symptoms and BPH-related complications. TURP is the reference standard for BPH surgery, but carries a risk of bleeding, which can lead to significant perioperative morbidity and mortality. To reduce bleeding during TURP, antifibrinolytic agents like tranexamic acid (TXA) have been studied. We aim to review the current evidence regarding TXA use during transurethral BPH surgery. Objective: This review aims to assess the efficacy and safety of tranexamic acid in reducing bleeding during transurethral benign prostatic hyperplasia surgery. Methods: Major clinical research databases such as PubMed, Cochrane Central Register of Controlled Trials, EBSCO, Scopus, Google Scholar, and Web of Science were searched from 2012 to 2022 for randomised controlled trials (RCTs) comparing the use of TXA to placebo in transurethral BPH surgery using the PICOS format. We included RCTs without language restrictions that assessed intraoperative blood loss, transfusion rates, haemoglobin levels, length of hospital stay, postoperative thromboembolic events, and 30-day perioperative mortality as outcomes. The quality assessment of the included studies was performed using the Cochrane risk-of-bias tool, RoB 2, for randomised studies. Results: A total of six RCTs, which included 456 patients, were eventually included in the meta-analysis. The results showed that tranexamic acid is beneficial in reducing blood loss and minimising changes in haemoglobin levels during transurethral resection of the prostate. However, it does not lessen the need for blood transfusions or shorten the hospital stay. Conclusions: Tranexamic acid is useful in decreasing blood loss and reducing changes in haemoglobin in patients undergoing transurethral resection of the prostate. Its utility during BPH surgery in low-resource settings where the latest haemostatic enucleation techniques, such as holmium and GreenLight laser enucleation, may not be readily available needs further evaluation.https://www.mdpi.com/2563-6499/5/6/60tranexamic acidbenign prostatic hyperplasiatransurethral benign prostatic hyperplasia surgerytransurethral resection of the prostate
spellingShingle Taofiq Olayinka Mohammed
Prashant M. Mulawkar
Pankaj Nandkishore Maheshwari
Abhishek Gajendra Singh
Vineet Gauhar
Gyanendra Sharma
Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
Société Internationale d’Urologie Journal
tranexamic acid
benign prostatic hyperplasia
transurethral benign prostatic hyperplasia surgery
transurethral resection of the prostate
title Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
title_full Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
title_fullStr Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
title_full_unstemmed Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
title_short Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
title_sort systematic review and meta analysis on the effectiveness of tranexamic acid in controlling bleeding during transurethral benign prostatic hyperplasia surgery
topic tranexamic acid
benign prostatic hyperplasia
transurethral benign prostatic hyperplasia surgery
transurethral resection of the prostate
url https://www.mdpi.com/2563-6499/5/6/60
work_keys_str_mv AT taofiqolayinkamohammed systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery
AT prashantmmulawkar systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery
AT pankajnandkishoremaheshwari systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery
AT abhishekgajendrasingh systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery
AT vineetgauhar systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery
AT gyanendrasharma systematicreviewandmetaanalysisontheeffectivenessoftranexamicacidincontrollingbleedingduringtransurethralbenignprostatichyperplasiasurgery